【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 13
2 Introduction 14
2.1 Infectious Diagnostics Rapid & Point of Care Tests Overview 14
3 Products under Development 15
3.1 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Stage of Development 15
3.2 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Segment 16
3.3 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Territory 17
3.4 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Regulatory Path 19
3.5 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Estimated Approval Date 20
4 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products under Development by Companies 21
4.1 Infectious Diagnostics Rapid & Point of Care Tests Companies – Pipeline Products by Stage of Development 21
4.2 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Stage of Development 24
5 Infectious Diagnostics Rapid & Point of Care Tests Companies and Product Overview 29
5.1 A&B Professional di Barsali Brunella Company Overview 29
5.1.1 A&B Professional di Barsali Brunella Pipeline Products & Ongoing Clinical Trials Overview 29
5.2 Akers Biosciences, Inc. Company Overview 30
5.2.1 Akers Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.3 Analyticon Biotechnologies AG Company Overview 34
5.3.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 34
5.4 Aseptika Ltd Company Overview 36
5.4.1 Aseptika Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
5.5 Atomo Diagnostics Pty Limited Company Overview 37
5.5.1 Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 37
5.6 Autoimmune Technologies, LLC Company Overview 39
5.6.1 Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 39
5.7 BACTERIOSCAN LTD. Company Overview 40
5.7.1 BACTERIOSCAN LTD. Pipeline Products & Ongoing Clinical Trials Overview 40
5.8 Biocartis SA Company Overview 41
5.8.1 Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview 41
5.9 BioFire Diagnostics, Inc. Company Overview 42
5.9.1 BioFire Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.10 Biotech Consortium India Limited Company Overview 43
5.10.1 Biotech Consortium India Limited Pipeline Products & Ongoing Clinical Trials Overview 43
5.11 Calypte Biomedical Corporation Company Overview 47
5.11.1 Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview 47
5.12 Canon U.S.A., Inc. Company Overview 50
5.12.1 Canon U.S.A., Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.13 Cepheid Company Overview 51
5.13.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 51
5.14 Coris BioConcept Company Overview 63
5.14.1 Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview 63
5.15 Denka Seiken Co., Ltd. Company Overview 64
5.15.1 Denka Seiken Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
5.16 Diagnostics for the Real World (Europe) Ltd. Company Overview 65
5.16.1 Diagnostics for the Real World (Europe) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 65
5.17 DIESSE Diagnostica Senese S.p.A. Company Overview 66
5.17.1 DIESSE Diagnostica Senese S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 66
5.18 First Light Biosciences, Inc. Company Overview 67
5.18.1 First Light Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.19 Foundation for Innovative New Diagnostics Company Overview 68
5.19.1 Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 68
5.20 Genalyte, Inc. Company Overview 76
5.20.1 Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
5.21 GeneFluidics Inc. Company Overview 77
5.21.1 GeneFluidics Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.22 Great Basin Corporation Company Overview 79
5.22.1 Great Basin Corporation Pipeline Products & Ongoing Clinical Trials Overview 79
5.23 Hema Diagnostic Systems, LLC Company Overview 80
5.23.1 Hema Diagnostic Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 80
5.24 Immunexpress Pty Ltd Company Overview 81
5.24.1 Immunexpress Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 81
5.25 ImmunoScience, Inc. Company Overview 82
5.25.1 ImmunoScience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
5.26 InBios International, Inc. Company Overview 88
5.26.1 InBios International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
5.27 Infectious Disease Research Institute Company Overview 91
5.27.1 Infectious Disease Research Institute Pipeline Products & Ongoing Clinical Trials Overview 91
5.28 Innova Biotechnology Co., Ltd. Company Overview 92
5.28.1 Innova Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 92
5.29 Insilixa, Inc. Company Overview 96
5.29.1 Insilixa, Inc. Pipeline Products & Ongoing Clinical Trials Overview 96
5.30 Institut de Recherche pour le Developpement Company Overview 98
5.30.1 Institut de Recherche pour le Developpement Pipeline Products & Ongoing Clinical Trials Overview 98
5.31 Institut Pasteur Company Overview 101
5.31.1 Institut Pasteur Pipeline Products & Ongoing Clinical Trials Overview 101
5.32 Integrated DNA Technologies, Inc. Company Overview 102
5.32.1 Integrated DNA Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 102
5.33 James Cook University Company Overview 103
5.33.1 James Cook University Pipeline Products & Ongoing Clinical Trials Overview 103
5.34 Labsystems Diagnostics Oy Company Overview 104
5.34.1 Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 104
5.35 Leiden University Company Overview 107
5.35.1 Leiden University Pipeline Products & Ongoing Clinical Trials Overview 107
5.36 Life Technologies Corporation Company Overview 108
5.36.1 Life Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 108
5.37 Lucigen Corporation Company Overview 109
5.37.1 Lucigen Corporation Pipeline Products & Ongoing Clinical Trials Overview 109
5.38 Meru University of Science & Technology Company Overview 110
5.38.1 Meru University of Science & Technology Pipeline Products & Ongoing Clinical Trials Overview 110
5.39 Micronics, Inc. (of Sony Group) Company Overview 111
5.39.1 Micronics, Inc. (of Sony Group) Pipeline Products & Ongoing Clinical Trials Overview 111
5.40 NexGen Arrays Company Overview 116
5.40.1 NexGen Arrays Pipeline Products & Ongoing Clinical Trials Overview 116
5.41 NOWDiagnostics Company Overview 117
5.41.1 NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 117
5.42 OptiCul Diagnostics Ltd. Company Overview 132
5.42.1 OptiCul Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 132
5.43 PrimerDesign Limited Company Overview 133
5.43.1 PrimerDesign Limited Pipeline Products & Ongoing Clinical Trials Overview 133
5.44 Protein Advances Inc. Company Overview 134
5.44.1 Protein Advances Inc. Pipeline Products & Ongoing Clinical Trials Overview 134
5.45 Quidel Corporation Company Overview 136
5.45.1 Quidel Corporation Pipeline Products & Ongoing Clinical Trials Overview 136
5.46 Quotient Limited Company Overview 140
5.46.1 Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview 140
5.47 Randox Laboratories Limited Company Overview 142
5.47.1 Randox Laboratories Limited Pipeline Products & Ongoing Clinical Trials Overview 142
5.48 Rockefeller University Company Overview 143
5.48.1 Rockefeller University Pipeline Products & Ongoing Clinical Trials Overview 143
5.49 Sedia Biosciences Corporation Company Overview 144
5.49.1 Sedia Biosciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 144
5.50 Sight Diagnostics Ltd. Company Overview 145
5.50.1 Sight Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 145
5.51 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 146
5.51.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 146
5.52 Standard Diagnostics, Inc. Company Overview 147
5.52.1 Standard Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 147
5.53 The Johns Hopkins University Company Overview 149
5.53.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 149
5.54 U.S. Army Medical Research Institute of Infectious Diseases Company Overview 151
5.54.1 U.S. Army Medical Research Institute of Infectious Diseases Pipeline Products & Ongoing Clinical Trials Overview 151
5.55 University of California, Berkeley Company Overview 152
5.55.1 University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview 152
5.56 University of California, Irvine Company Overview 154
5.56.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 154
5.57 University of Edinburgh Company Overview 156
5.57.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 156
5.58 University of Nevada, Reno Company Overview 157
5.58.1 University of Nevada, Reno Pipeline Products & Ongoing Clinical Trials Overview 157
5.59 University of Oxford Company Overview 163
5.59.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 163
5.60 University of Virginia Company Overview 164
5.60.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 164
5.61 Vircell S.L Company Overview 165
5.61.1 Vircell S.L Pipeline Products & Ongoing Clinical Trials Overview 165
5.62 Wholehealth Products, Inc. Company Overview 170
5.62.1 Wholehealth Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 170
5.63 Yale University Company Overview 171
5.63.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 171
5.64 Yeda Research and Development Company Ltd. Company Overview 172
5.64.1 Yeda Research and Development Company Ltd. Pipeline Products & Ongoing Clinical Trials Overview 172
6 Infectious Diagnostics Rapid & Point of Care Tests- Recent Developments 174
7 Appendix 210
7.1 Methodology 210
7.2 About GlobalData 212
7.3 Contact Us 213
7.4 Disclaimer 213
【レポート販売概要】
■ タイトル：世界における感染症迅速/POC検査製品のパイプライン動向2015■ 英文：Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0084EPD
■ 調査対象地域：グローバル
- チオフェンの世界市場Thiophene (CAS 110-02-1) Market Research Report 2014 presents comprehensive data on thiophene markets globally and regionally (Europe, Asia, North America etc.) The report includes thiophene description, covers its application areas and related patterns. It overviews thiophene market, names thiophene producers and indicates its suppliers. Besides, the report provides thiophene prices in regional m …
- 世界のアフェレーシス装置市場：製品別、地域別Global Apheresis Devices Market: About this market Technavio’s apheresis devices market analysis considers sales from both systems and consumable products. Our study also finds the sales of apheresis devices in Asia, Europe, North America, and ROW. In 2019, the apheresis system segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as …
- オピオイドの世界市場：製品別（コデイン、フェンタニル、メタドン、オキシコドン、モルヒネ、ヒドロコドンなど）、用途別（疼痛管理、咳治療、下痢）The global opioids market was valued at $18,532.8 million in 2018, and is expected to reach $22,387.2 million by 2026, registering a CAGR of 3.2% from 2019 to 2026. Opioids are drugs that stimulate the brain to produce a variety of effects, including pain relief. The term opioid refers to all substances (exogenous or endogenous) that possess morphine-like properties. Opioids are the most widely pr …
- 排液排出ゼロ（ZLD）システムの世界市場予測（～2023年）“The zero liquid discharge systems market is projected to grow at a CAGR of 8.3% between 2018 and 2023.”The zero liquid discharge (ZLD) systems market is estimated to be USD 5.4 billion in 2018 and is projected to reach USD 8.1 billion by 2023, at a CAGR of 8.3% from 2018 to 2023. Key factors expected to drive the zero liquid discharge systems market include the implementation of stringent environ …
- B型肝炎ウイルス（HPV）治療市場：アメリカの治療薬市場Hepatitis B Virus (HBV) Therapeutics - US Drug Forecast and Market Analysis to 2024 Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains a serious global health concern, with estimated over 350 million people worldw …
- 全般発作治療のグローバル臨床試験動向（2014年H2）Generalized Seizures Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Generalized Seizures Global Clinical Trials Review, H2, 2014" provides data on the Generalized Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Generalized Seizures. It includes an overview of the trial numbers and their r …
- 世界の ユニファイド コミュニケーション市場動向（2012-2016）TechNavio's analysts forecast the Global Unified Communication market to grow at a CAGR of 15.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the shift from on-premises to cloud-based unified communication. The Global Unified Communication market has also been witnessing the unified communication heading towards WebRTC. However, the initial high c …
- プロピレングリコール(PG)の世界市場予測Propylene glycol 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about propylene glycol market in the all-in-one report issued in a logical and easily accessible format. In addition to the analyti …
- Omaha Public Power District：発電所及びSWOT分析2013Omaha Public Power District - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summar …
- 重量式道路ろ過のアフターマーケットの世界市場分析：製品別（オイル、エア、キャビン、燃料）、用途別（トラック・バス、建設、鉱業、農業）、セグメント予測The heavy duty road filtration aftermarket industry is expected to reach USD 1.01 billion by 2024, according to a new report by Grand View Research, Inc. Rising environmental concern across countries coupled with new norms issued by the government is expected to aid the aftermarket sales for heavy duty road filtration products over the forecast period. To curb the alarming effect of air pollution, …
- Molnlycke Health Care AB：市場シェア分析Molnlycke Health Care AB Market Share Analysis Summary GlobalData’s new report, “Molnlycke Health Care AB Market Share Analysis” provides in-depth information on Molnlycke Health Care AB’s market position in the different medical equipment markets it operates in. The report provides Molnlycke Health Care AB market share information in four key market categories – Disposable Hospital Supplies, Adva …
- Athabasca Oil Corporation：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Athabasca Oil Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Athabasca Oil Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essentia …
- 2014年戦略提言：ドイツの病院内感染症検査市場This new report from Venture Planning Group contains 897 pages, 74 tables, and presents a comprehensive analysis of the German hospital infectious disease testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. …
- 世界の商業用航空飛行管理システム市場The report deals with Flight Management Systems which mainly aims at integrating navigation, flight parameters and navigation to get a systematic and consolidated auto flight control which maximizes the aircraft efficiency. Flight Safety is the major concern of all the aircraft operators as well as the airlines which demands the improvisation in FMS technology every year resulting in the growth of …
- 農業用ドローンの世界市場分析：製品別（固定翼、回転板、ハイブリッド）、用途別（フィールドマッピング、可変レートアプリケーション、作物スカウト）、セグメント予測 -2024The global agriculture drone market is expected to reach USD 3,770.0 million by 2024, according to a new report by Grand View Research, Inc. The increasing technological advancements in equipment and for enhancing the quality of the farming techniques have led to the increased implementation of agriculture drones in the market. Increasing automation in the agriculture process, owing to the labor c …
